![Sam Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sam Jackson worked as an Executive Director of Clinical Development at Dynavax Technologies Corp.
and as a Chief Medical Officer at Alkahest, Inc. He also worked as a Senior Vice President of Clinical Sciences at Alector, Inc. from 2020 to 2021.
Jackson holds a Master's in Business Administration and a doctorate from the University of Pennsylvania.
| Unternehmen | Position | Ende |
|---|---|---|
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Operates as a research and drug discovery company | Technik-/Wissenschafts-/F&E-Leiter | - |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | - |
| ALECTOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Operates as a research and drug discovery company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
